Literature DB >> 27569581

Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex.

Nasim F Mehrabi1, Henry J Waldvogel1, Lynette J Tippett2, Virginia M Hogg2, Beth J Synek3, Richard L M Faull4.   

Abstract

BACKGROUND: Huntington's disease (HD) is characterised by variable symptoms and neuropathology of the basal ganglia and cortex. Previously, we have shown that the pattern of pyramidal cell loss in 8 different cortical regions correlates with the phenotypic variability in HD. In the primary motor and anterior cingulate cortices, the pattern of interneuron degeneration correlates with pyramidal cell death and variable HD symptom profiles.
OBJECTIVES: This study aimed to examine the pattern of interneuron degeneration in 3 further regions of the HD cortex (primary sensory, superior frontal, superior parietal cortices) to determine whether HD neuropathogenesis was characterised by a general fundamental pattern of cortical interneuron loss, and explore the relationship between cortical interneuron loss with previously determined pyramidal cell loss and clinical heterogeneity.
METHODS: Stereological counting was used to quantify 3 sub-populations of calcium-binding protein containing interneurons in 3 cortical human brain regions of 14 HD and 13 control cases as used in our previous studies (Nana et al., 2014; Kim et al., 2014). The HD cases were grouped according to their predominant symptom profile ("motor", "mood", "mixed").
RESULTS: The present results demonstrated a heterogeneous loss of interneurons across the 3 cortical regions which, when compared with our previous studies, mirrored the pattern of pyramidal cell loss in the same cortical areas. Most interestingly, the pattern of neuronal loss in these regions correlated with the variable HD symptom profiles.
CONCLUSION: The overall findings in our present and previous cortical studies establish a clear correlative pattern of variable cortical neuronal degeneration in HD pathogenesis, which mirrors the heterogeneity of HD symptom phenotypes.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Cerebral cortex; Huntington's disease; Interneurons; Pathology; Pyramidal cells; Variable symptoms

Mesh:

Year:  2016        PMID: 27569581     DOI: 10.1016/j.nbd.2016.08.015

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

Review 2.  Therapeutic approaches to Huntington disease: from the bench to the clinic.

Authors:  Nicholas S Caron; E Ray Dorsey; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2018-09-21       Impact factor: 84.694

Review 3.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

4.  Preparation, construction and high-throughput automated analysis of human brain tissue microarrays for neurodegenerative disease drug development.

Authors:  Malvindar K Singh-Bains; Nasim F Mehrabi; Adelie Y S Tan; Richard L M Faull; Mike Dragunow
Journal:  Nat Protoc       Date:  2021-03-19       Impact factor: 13.491

Review 5.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

Review 6.  Evaluating the current state of the art of Huntington disease research: a scientometric analysis.

Authors:  L A Barboza; N C Ghisi
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

Review 7.  Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.

Authors:  Anne-Claire Dupont; Bérenger Largeau; Maria Joao Santiago Ribeiro; Denis Guilloteau; Claire Tronel; Nicolas Arlicot
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

8.  Cerebellar degeneration correlates with motor symptoms in Huntington disease.

Authors:  Malvindar K Singh-Bains; Nasim F Mehrabi; Tvesa Sehji; Micah D R Austria; Adelie Y S Tan; Lynette J Tippett; Mike Dragunow; Henry J Waldvogel; Richard L M Faull
Journal:  Ann Neurol       Date:  2019-02-04       Impact factor: 10.422

9.  Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease.

Authors:  Clara Garcia-Gorro; Alberto Llera; Saul Martinez-Horta; Jesus Perez-Perez; Jaime Kulisevsky; Nadia Rodriguez-Dechicha; Irene Vaquer; Susana Subira; Matilde Calopa; Esteban Muñoz; Pilar Santacruz; Jesus Ruiz-Idiago; Celia Mareca; Christian F Beckmann; Ruth de Diego-Balaguer; Estela Camara
Journal:  Neuroimage Clin       Date:  2019-06-15       Impact factor: 4.881

10.  Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington's Disease.

Authors:  Christopher D Rowley; Sarah J Tabrizi; Rachael I Scahill; Blair R Leavitt; Raymund A C Roos; Alexandra Durr; Nicholas A Bock
Journal:  Front Neurosci       Date:  2018-11-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.